Back to Search
Start Over
PT010 Phase III ETHOS trial met its primary endpoint in chronic obstructive pulmonary disease
- Source :
- Plus Company Updates. August 29, 2019
- Publication Year :
- 2019
-
Abstract
- WILMINGTON: AstraZeneca has issued the following press release: AstraZeneca today announced positive results from the Phase III ETHOS trial for triple-combination therapy PT010 in patients with moderate to very severe [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.597739990